DMD Advocates Lose Approval but Win One Step Ahead in Advocacy
In today’s New York Times, Andrew Pollack reports on the FDA Advisory Committee “no” vote for a new treatment for Duchenne muscular dystrophy. This is the second time in recent…
In today’s New York Times, Andrew Pollack reports on the FDA Advisory Committee “no” vote for a new treatment for Duchenne muscular dystrophy. This is the second time in recent…
Topline findings from a survey of more than 600 caregivers now available for download.
Learn More